Jamie Raskin actually said...
According to the non-partisan CBO, allowing the Federal Government to negotiate directly with drug companies could lower spending on brand name drugs by about $456 billion.
Context
Raskin highlights potential savings from government negotiation with drug companies.
09/30/2020